ArticlePloS one2021

Low-dose urokinase thrombolytic therapy for patients with acute intermediate-high-risk pulmonary embolism: A retrospective cohort study.

Cuilian Weng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.